Pharmacokinetic parameters (mean ± SD) obtained for flubendazole (FLBZ) and its hydrolyzed metabolite (H-FLBZ) after treatment (5 mg/kg) with different FLBZ formulations to uninfected rats: Cyclodextrin-based (FLBZ-CD_oral or FLBZ-CD_sc), Tween-based (FLBZ-TWEEN) and carboxy met

Cmax: peak plasma concentration; Tmax: time to peak plasma concentration; AUC0-LOQ: area under the concentration vs. time curve from 0 up to the limit of quantification. Different letters indicate statistically significant differences (P<0.05) between experimental groups.